Residual tumor volume and survival after CCNU/TMZ in GBM

from Neuro-Oncology: The Podcast · host Drs. Iyad Alnahhas, Thomas Zeyen and Johannes Weller

Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.

Episode metadata supplied by the publisher feed · Published Nov 24, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Residual tumor volume and survival after CCNU/TMZ in GBM

0:00 13:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 13 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on November 24, 2024.

Can I download this Neuro-Oncology: The Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!